Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $231.63 million. The enterprise value is -$74.10 million.

Market Cap	231.63M
Enterprise Value	-74.10M

Important Dates

The last earnings date was Monday, March 3, 2025, before market open.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

NMRA has 161.98 million shares outstanding. The number of shares has increased by 145.12% in one year.

Current Share Class	161.98M
Shares Outstanding	161.98M
Shares Change (YoY)	+145.12%
Shares Change (QoQ)	+0.88%
Owned by Insiders (%)	5.81%
Owned by Institutions (%)	54.79%
Float	85.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.81
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.51, with a Debt / Equity ratio of 0.01.

Current Ratio	10.51
Quick Ratio	10.29
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.48% and return on invested capital (ROIC) is -43.15%.

Return on Equity (ROE)	-64.48%
Return on Assets (ROA)	-40.50%
Return on Invested Capital (ROIC)	-43.15%
Return on Capital Employed (ROCE)	-91.77%
Revenue Per Employee	n/a
Profits Per Employee	-$2.22M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $178,000 in taxes.

Income Tax	178,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-92.06%
50-Day Moving Average	2.61
200-Day Moving Average	9.25
Relative Strength Index (RSI)	29.76
Average Volume (20 Days)	1,429,081

Short Selling Information

The latest short interest is 11.20 million, so 6.91% of the outstanding shares have been sold short.

Short Interest	11.20M
Short Previous Month	10.26M
Short % of Shares Out	6.91%
Short % of Float	13.13%
Short Ratio (days to cover)	4.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-263.46M
Pretax Income	-273.79M
Net Income	-243.79M
EBITDA	-262.83M
EBIT	-263.46M
Earnings Per Share (EPS)	-$1.53

Full Income Statement

Balance Sheet

The company has $307.58 million in cash and $1.85 million in debt, giving a net cash position of $305.73 million or $1.89 per share.

Cash & Cash Equivalents	307.58M
Total Debt	1.85M
Net Cash	305.73M
Net Cash Per Share	$1.89
Equity (Book Value)	287.06M
Book Value Per Share	1.78
Working Capital	284.17M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-182.94M
Capital Expenditures	n/a
Free Cash Flow	-182.94M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-145.12%
Shareholder Yield	-145.12%
Earnings Yield	-105.25%
FCF Yield	-78.98%

Analyst Forecast

The average price target for NMRA is $10.14, which is 609.09% higher than the current price. The consensus rating is "Buy".

Price Target	$10.14
Price Target Difference	609.09%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1